Literature DB >> 16375710

Crimean-Congo hemorrhagic fever virus.

Ramon Flick1, Chris A Whitehouse.   

Abstract

Crimean-Congo hemorrhagic fever virus (CCHFV) is an important human pathogen, which is the cause of a tick-borne illness occurring in many areas of Africa, Asia, and Europe. CCHF is characterized by a sudden onset of high fever, chills, and severe headache. Other symptoms can include gastrointestinal disorders, such as nausea, vomiting, and diarrhea. In severe cases, hemorrhagic manifestations can occur and often present as large areas of ecchymosis, rather than frank bleeding. Exposure to ticks, particularly those in the genus Hyalomma, or direct contact with virus-infected animals or people are considered the major risk factors. Studies on CCHFV are impeded by the biocontainment needed for their manipulation. However, the increasing worldwide medical awareness, the enormous interest of the media in hemorrhagic fever diseases, and their potential to be used as a bioweapon, have greatly spurred on research on this important virus, as evidenced by many new developments including the development of a reverse genetics system which should greatly enhance future research with this virus.

Entities:  

Mesh:

Year:  2005        PMID: 16375710     DOI: 10.2174/156652405774962335

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  22 in total

1.  Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus.

Authors:  S M Ghiasi; A H Salmanian; S Chinikar; S Zakeri
Journal:  Clin Vaccine Immunol       Date:  2011-10-19

Review 2.  The role of ticks in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus: A review of published field and laboratory studies.

Authors:  Aysen Gargili; Agustin Estrada-Peña; Jessica R Spengler; Alexander Lukashev; Patricia A Nuttall; Dennis A Bente
Journal:  Antiviral Res       Date:  2017-06-01       Impact factor: 5.970

3.  Crimean-Congo hemorrhagic fever virus nucleoprotein reveals endonuclease activity in bunyaviruses.

Authors:  Yu Guo; Wenming Wang; Wei Ji; Maping Deng; Yuna Sun; Honggang Zhou; Cheng Yang; Fei Deng; Hualin Wang; Zhihong Hu; Zhiyong Lou; Zihe Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-14       Impact factor: 11.205

4.  Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever.

Authors:  Ana Saksida; Darja Duh; Branka Wraber; Isuf Dedushaj; Salih Ahmeti; Tatjana Avsic-Zupanc
Journal:  Clin Vaccine Immunol       Date:  2010-05-19

5.  Crimean-Congo hemorrhagic fever: Risk factors and control measures for the infection abatement.

Authors:  Saadia Aslam; Muhammad Shahzad Latif; Muhammad Daud; Zia Ur Rahman; Bushra Tabassum; Muhammad Sohail Riaz; Anwar Khan; Muhammad Tariq; Tayyab Husnain
Journal:  Biomed Rep       Date:  2015-11-18

6.  Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy.

Authors:  Marko Zivcec; David Safronetz; Dana Scott; Shelly Robertson; Hideki Ebihara; Heinz Feldmann
Journal:  J Infect Dis       Date:  2013-02-15       Impact factor: 5.226

7.  Mapping of the interaction domains of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein.

Authors:  Jesica M Levingston Macleod; Hannah Marmor; Adolfo García-Sastre; Natalia Frias-Staheli
Journal:  J Gen Virol       Date:  2014-11-11       Impact factor: 3.891

8.  Crimean-Congo hemorrhagic fever virus nucleocapsid protein harbors distinct RNA-binding sites in the stalk and head domains.

Authors:  Subbiah Jeeva; Sheema Mir; Adrain Velasquez; Jacquelyn Ragan; Aljona Leka; Sharon Wu; Ariga Tahmasian Sevarany; Austin D Royster; Nicholas A Almeida; Fion Chan; Lea O'Brien; Mohammad Ayoub Mir
Journal:  J Biol Chem       Date:  2019-02-05       Impact factor: 5.157

Review 9.  Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.

Authors:  Michele Bouloy; Ramon Flick
Journal:  Antiviral Res       Date:  2009-08-12       Impact factor: 5.970

10.  Structural and Functional Diversity of Nairovirus-Encoded Nucleoproteins.

Authors:  Wenming Wang; Xiang Liu; Xu Wang; Hui Dong; Chao Ma; Jingmin Wang; Baocheng Liu; Yonghong Mao; Ying Wang; Ting Li; Cheng Yang; Yu Guo
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.